Search Within

Genitourinary Oncology Service

  1. "Eugene Cha"
Formats
  1. Meeting Abstract (44)
  2. Journal Article (26)
  3. Correspondence (1)
Groups
  1. Department of Medicine (71)
  2. Solid Tumor Oncology Division (71)
  3. Surgery (71)
  4. Urology (71)
  5. Department of Pathology and Laboratory Medicine (64)
  6. Human Oncology and Pathogenesis Program (60)

More Groups

People
  1. Eugene Cha (71)
  2. Bernard Bochner (62)
  3. Hikmat Al-Ahmadie (61)
  4. Gopakumar Iyer (58)
  5. David Solit (56)
  6. Dean Bajorin (56)

More People

Years
  1. 2025 (3)
  2. 2024 (3)
  3. 2023 (2)
  4. 2022 (6)
  5. 2021 (5)
  6. 2020 (4)

More Years

Publications
  1. Journal of Clinical Oncology (26)
  2. Modern Pathology (9)
  3. Laboratory Investigation (8)
  4. European Urology (4)
  5. Clinical Cancer Research (3)
  6. JCO Precision Oncology (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (29)
  2. Nature Publishing Group (10)
  3. Nature Research (9)
  4. Elsevier Science, Inc. (7)
  5. American Association for Cancer Research (5)
  6. Elsevier Inc. (4)

More Publishers

Results (71)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Re-analysis of intravesical gemcitabine in the era of Bacillus Calmette-Guérin (BCG)-unresponsive non–muscle-invasive bladder cancer
    Journal Article

    De Jesus Escano, M. R.; Vertosick, E. A.; D'Souza, N.; Benfante, N.; Lenis, A. T.; Reisz, P. A.; Gaffney, C.; Goh, A.; Donahue, T. F.; Cha, E.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Clinical outcomes, genomic heterogeneity, and therapeutic considerations across histologic subtypes of urothelial carcinoma
    Journal Article

    Chu, C. E.; Chen, Z.; Whiting, K.; Ostrovnaya, I.; Lenis, A. T.; Clinton, T. N.; Rammal, R.; Ozcan, G. G.; Akbulut, D.; Basar, M.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Updated long-term follow-up from a phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma
    Meeting Abstract

    Jayalath, V.; Teo, M. Y.; Assel, M.; Rodriguez, D.; Meyerson, A.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Cha, E. K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Neoadjuvant nivolumab (N) + ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC): Updated results
    Meeting Abstract

    Sternschuss, M.; Guercio, B. J.; Pietzak, E. J.; Ponomarev, M.; Regazzi, A. M.; Quinlan, C.; Aggen, D. H.; Goh, A. C.; Cha, E. K.; Donat, S. M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Natural history and genomic landscape of chemotherapy-resistant muscle-invasive bladder cancer
    Journal Article

    Lenis, A. T.; Whiting, K.; Ravichandran, V.; Tallman, J. E.; Alam, S. M.; Chu, C. E.; De Jesus Escano, M.; Bochner, E.; Katims, A.; Reisz, P. A.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Changes in the perioperative management and outcomes of patients with upper tract urothelial carcinoma undergoing radical nephroureterectomy at Memorial Sloan Kettering Cancer Center: Over 20 years of experience
    Journal Article

    Yip, W.; Assel, M. J.; Wong, N. C.; Tracey, A. T.; Alvim, R. G.; Nogueira, L.; Almassi, N.; Singla, N.; Clinton, T. N.; Sjoberg, D. D.; more...
    Urology Practice (2024)

    Fulltext@MSK | Save
  • Multicenter phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma
    Journal Article

    Coleman, J. A.; Yip, W.; Wong, N. C.; Sjoberg, D. D.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Cha, E. K.; Donahue, T. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Neoadjuvant nivolumab (N) + ipilimumab (I) in cisplatin-ineligible patients with upper tract urothelial cancer (UTUC)
    Meeting Abstract

    Teo, M. Y.; Guercio, B. J.; Pietzak, E. J.; Ponomarev, M.; Regazzi, A. M.; Quinlan, C.; Aggen, D. H.; Donahue, T. F.; Goh, A. C.; Cha, E. K.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Clinical and genomic characterization of bladder carcinomas with glandular phenotype
    Journal Article

    Almassi, N.; Whiting, K.; Toubaji, A.; Lenis, A. T.; Jordan, E. J.; Won, H.; Regazzi, A. M.; Chen, Y. B.; Gopalan, A.; Sirintrapun, S. J.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • Phase I study of intravesical anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer unresponsive to Bacillus Calmette-Guerin (BCG) therapy
    Meeting Abstract

    Wong, J. L.; Knorr, D.; Whiting, K.; Seshan, V. E.; Pietzak, E. J.; Donahue, T. F.; Cha, E. K.; Goh, A. C.; Smith, R.; Dalbagni, G.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save